ocal application for Fungal infectio
Phase 2
- Conditions
- Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2024/07/070470
- Lead Sponsor
- Dr Nalina D S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients who will give written consent.
2)Patients who fulfil the diagnostic criteria.
3)Patients who are suffering from infection not more than 6 months.
4)Patients suffering from Tinea corporis.
Exclusion Criteria
1)Patients associated with other type of Kushta.
2)Patient taking immunosuppressive medicine
3)Patient who is on other antifungal therapy.
4)Patient with a previous allergic reaction to a specific treatment.
5)Patients who have lesions with secondary infections like eczematisation, cellulitis etc.
6)Patients with any other systemic disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To check the parameters and assess the symptoms <br/ ><br>1)itching <br/ ><br>2)circular lesion <br/ ><br> <br/ ><br>To assess the efficacy of drug Arka tailaTimepoint: At Day 0 , Day 8, Day 15, Day 22, Day 32, Day 42
- Secondary Outcome Measures
Name Time Method to check the parameters and assess the symptoms <br/ ><br>1)Raga <br/ ><br>2)Pidaka <br/ ><br>3)Daha <br/ ><br>4)Rookshata <br/ ><br>Timepoint: 42 days